Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2024 Apr;55(4):908-918.
doi: 10.1161/STROKEAHA.123.045731. Epub 2024 Feb 9.

Antithrombotic Treatment for Stroke Prevention in Cervical Artery Dissection: The STOP-CAD Study

Shadi Yaghi  1 Liqi Shu  1 Daniel Mandel  1 Christopher R Leon Guerrero  2 Nils Henninger  3 Jayachandra Muppa  3 Muhammad Affan  4 Omair Ul Haq Lodhi  4 Mirjam R Heldner  5 Kateryna Antonenko  5 David Seiffge  5 Marcel Arnold  5 Setareh Salehi Omran  6 Ross Crandall  6 Evan Lester  7 Diego Lopez Mena  8 Antonio Arauz  8 Ahmad Nehme  9 Marion Boulanger  9 Emmanuel Touze  9 Joao Andre Sousa  10 Joao Sargento-Freitas  10 Vasco Barata  10 Paulo Castro-Chaves  11 Maria Teresa Brito  11 Muhib Khan  12 Dania MallickAaron Rothstein  13 Ossama Khazaal  13 Josefin E Kaufmann  14 Stefan T Engelter  14 Christopher Traenka  14 Diana Aguiar de Sousa  15 Mafalda Soares  16 Sara Rosa  17 Lily W Zhou  18 Preet Gandhi  18 Thalia S Field  18 Steven Mancini  18 Issa Metanis  19 Ronen R Leker  19 Kelly Pan  1 Vishnu Dantu  1 Karl Baumgartner  1 Tina Burton  1 Regina Von Rennenberg  20 Christian H Nolte  20 Richard Choi  21 Jason MacDonald  21 Reza Bavarsad Shahripour  22 Xiaofan Guo  23 Malik Ghannam  24 Mohammad Almajali  24 Edgar A Samaniego  24 Sebastian Sanchez  24 Bastien Rioux  25 Faycal Zine-Eddine  25 Alexandre Poppe  25 Ana Catarina Fonseca  26 Maria Fortuna Baptista  26 Diana Cruz  26 Michele Romoli  27 Giovanna De Marco  27 Marco Longoni  27 Zafer Keser  28 Kim Griffin  28 Lindsey Kuohn  29 Jennifer Frontera  29 Jordan Amar  30 James Giles  30 Marialuisa Zedde  31 Rosario Pascarella  32 Ilaria Grisendi  31 Hipolito Nzwalo  33 David S Liebeskind  34 Amir Molaie  34 Annie Cavalier  35 Wayneho Kam  36 Brian Mac Grory  35 Sami Al Kasab  37 Mohammad Anadani  37 Kimberly Kicielinski  38 Ali Eltatawy  39 Lina Chervak  39 Roberto Chulluncuy-Rivas  39 Yasmin Aziz  39 Ekaterina Bakradze  40 Thanh Lam Tran  40 Marc Rodrigo-Gisbert  41 Manuel Requena  41 Faddi Saleh Velez  42 Jorge Ortiz Gracia  42 Varsha Mudassani  43 Adam de Havenon  44   45 Venugopalan Y Vishnu  46 Sridhara Yaddanapudi  46 Latasha Adams  46 Abigail Browngoehl  46 Tamra Ranasinghe  47 Randy Dunston  47 Zachary Lynch  47 Mary Penckofer  48 James Siegler  48 Silvia Mayer  49 Joshua Willey  49 Adeel Zubair  44 Yee Kuang Cheng  44 Richa Sharma  44 João Pedro Marto  50 Vítor Mendes Ferreira  50 Piers Klein  51 Thanh N Nguyen  51 Syed Daniyal Asad  52 Zoha Sarwat  52 Anvesh Balabhadra  52 Shivam Patel  52 Thais Secchi  53 Sheila Martins  54 Gabriel Mantovani  54 Young Dae Kim  55 Balaji Krishnaiah  56 Cheran Elangovan  56 Sivani Lingam  57 Abid Quereshi  57 Sebastian Fridman  58 Alonso Alvarado  58 Farid Khasiyev  59 Guillermo Linares  59 Marina Mannino  60 Valeria Terruso  60 Sofia Vassilopoulou  61 Vasilis Tentolouris  61 Manuel Martinez-Marino  62 Victor Carrasco Wall  62 Fransisca Indraswari  63 Sleiman El Jamal  63 Shilin Liu  64 Muhammad Alvi  65 Farman Ali  65 Mohammed Sarvath  65 Rami Z Morsi  66 Tareq Kass-Hout  66 Feina Shi  67 Jinhua Zhang  67 Dilraj Sokhi  68 Jamil Said  68 Alexis N Simpkins  69 Roberto Gomez  69 Shayak Sen  69 Mohammad Ghani  70 Marwa Elnazeir  70 Han Xiao  71 Narendra Kala  1 Farhan Khan  1 Christoph Stretz  1 Nahid Mohammadzadeh  1 Eric Goldstein  1 Karen Furie
Affiliations
Free article
Observational Study

Antithrombotic Treatment for Stroke Prevention in Cervical Artery Dissection: The STOP-CAD Study

Shadi Yaghi et al. Stroke. 2024 Apr.
Free article

Abstract

Background: Small, randomized trials of patients with cervical artery dissection showed conflicting results regarding optimal stroke prevention strategies. We aimed to compare outcomes in patients with cervical artery dissection treated with antiplatelets versus anticoagulation.

Methods: This is a multicenter observational retrospective international study (16 countries, 63 sites) that included patients with cervical artery dissection without major trauma. The exposure was antithrombotic treatment type (anticoagulation versus antiplatelets), and outcomes were subsequent ischemic stroke and major hemorrhage (intracranial or extracranial hemorrhage). We used adjusted Cox regression with inverse probability of treatment weighting to determine associations between anticoagulation and study outcomes within 30 and 180 days. The main analysis used an as-treated crossover approach and only included outcomes occurring with the above treatments.

Results: The study included 3636 patients (402 [11.1%] received exclusively anticoagulation and 2453 [67.5%] received exclusively antiplatelets). By day 180, there were 162 new ischemic strokes (4.4%) and 28 major hemorrhages (0.8%); 87.0% of ischemic strokes occurred by day 30. In adjusted Cox regression with inverse probability of treatment weighting, compared with antiplatelet therapy, anticoagulation was associated with a nonsignificantly lower risk of subsequent ischemic stroke by day 30 (adjusted hazard ratio [HR], 0.71 [95% CI, 0.45-1.12]; P=0.145) and by day 180 (adjusted HR, 0.80 [95% CI, 0.28-2.24]; P=0.670). Anticoagulation therapy was not associated with a higher risk of major hemorrhage by day 30 (adjusted HR, 1.39 [95% CI, 0.35-5.45]; P=0.637) but was by day 180 (adjusted HR, 5.56 [95% CI, 1.53-20.13]; P=0.009). In interaction analyses, patients with occlusive dissection had significantly lower ischemic stroke risk with anticoagulation (adjusted HR, 0.40 [95% CI, 0.18-0.88]; Pinteraction=0.009).

Conclusions: Our study does not rule out the benefit of anticoagulation in reducing ischemic stroke risk, particularly in patients with occlusive dissection. If anticoagulation is chosen, it seems reasonable to switch to antiplatelet therapy before 180 days to lower the risk of major bleeding. Large prospective studies are needed to validate our findings.

Keywords: anticoagulants; arteries; hemorrhage; ischemic stroke; stroke.

PubMed Disclaimer

Conflict of interest statement

Disclosures Disclosures provided by Dr Nguyen in compliance with American Heart Association annual Journal Editor Disclosure Questionnaire are available at https://www.ahajournals.org/editor-coi-disclosures. Dr Arnold reports compensation from Boehringer Ingelheim, AstraZeneca, Bayer, Bristol-Myers Squibb, Covidien, Daiichi Sankyo, Novartis, Sanofi, Pfizer, Medtronic, Novo Nordisk, and Amgen for consultant services. Dr Lester reports a provisional patent for Methods and compositions for disrupting tau aggregates. Dr Touze reports compensation from Elsevier for other services and employment by Caen. J.E. Kaufman reports grants from Goldschmidt Jacobson-Stiftung. Dr Traenka reports travel support from Bayer Healthcare. Dr Aguiar de Sousa reports compensation from Daiichi Sankyo, Bayer, AstraZeneca, Johnson & Johnson, and Fundação Bial for other services; compensation from the University of British Columbia for data and safety monitoring services; compensation from Organon & Co for consultant services. Dr Rosa reports grants from Merck Sharp & Dohme Corporation. Dr Field reports compensation from HLS Therapeutics, AstraZeneca Canada, and Roche for consultant services; service as a board member for Destine Health; and compensation from the Canadian Medical Protective Association for expert witness services; and grants from Bayer. Dr Leker reports compensation from Medtronic, Ischemaview, Bayer, Abbott Diabetes Care, Biogen, Janssen Biotech, and Boehringer Ingelheim for other services. Dr Nolte reports compensation from Daiichi Sankyo Europe GmbH, Boehringer Ingelheim, Pfizer, Bristol-Myers Squibb, and Alexion Pharmaceuticals for consultant services; and compensation from AstraZeneca, Abbott Canada, Deutsches Zentrum für Neurodegenerative Erkrankungen, Novartis, Portola Pharmaceuticals, Deutsches Zentrum für Herz-Kreislaufforschung, and Novartis for other services. Dr Poppe reports grants from Foundation Brain Canada, Heart and Stroke Foundation of Canada, and Stryker; and compensation from Roche for other services. Dr Liebeskind reports compensation from Medtronic, Genentech, Cerenovus, Stryker, and Rapid Medical Ltd, for consultant services. B. Mac Grory reports grants from the National Institutes of Health; employment by Duke University Medical Center; compensation from Bayer for other services; grants from the American Heart Association, Duke Bass Connections, and the Duke Office of Physician Scientist Development. Dr Al Kasab reports compensation from Stryker for other services and employment by Medical University of South Carolina. Dr Kicielinski reports compensation from Stryker, Penumbra Inc, Medtronic, and MicroVention Inc, for other services; travel support from MicroVention Inc; and employment by Medical University of South Carolina and Elsevier. Dr de Havenon reports stock options in TitinKM and Certus; grants from the National Institutes of Health; and compensation from Novo Nordisk for consultant services. Dr Siegler reports grants from Philips and employment by the University of Chicago. Dr Willey reports compensation from Edwards Lifesciences Corporation and Abbott Fund for end point review committee services; compensation from Uptodate for other services; and compensation from the Abbott Laboratories for consultant services. Dr Sharma reports a provisional patent for a stroke etiology classifier algorithm and grants from the National Institutes of Health Clinical Center. Dr Martins reports compensation from Pfizer, Medtronic, Servier Affaires Medicales, Daiichi Sankyo, Bayer, Novo Nordisk, Novartis, Penumbra Inc, and Boehringer Ingelheim for other services. Dr Simpkins reports grants from the National Institutes of Health. Dr Stretz reports grants from Massachusetts General Hospital. Dr Furie reports compensation from Janssen Biotech for consultant services. The other authors report no conflicts

Comment in

References

Publication types

MeSH terms